Quick Order Cart

Cat. No. ARG37905

BICC1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

BICC1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T cells. This model disrupts the BICC1 gene, which encodes an RNA-binding protein that regulates Wnt/??-catenin and planar cell polarity signaling. BICC1 interacts with Dvl2 and Prickle1 and controls the translation of targets such as Cripto-1, Cyclin D1, and c-Myc. The knockout is suitable for studying Wnt pathway dynamics, kidney development, and cancer biology. Applications include reporter assays, migration studies, and drug screening in a highly transfectable host background. For more information, visit Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    BICC1

    Gene Identifier

    NCBI Gene ID 80114

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

BICC1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HEK293T cell line. These cells carry a targeted disruption of the BICC1 gene, providing a loss-of-function model to study the role of this RNA-binding protein in cell signaling, development, and disease. The polyclonal format ensures a heterogeneous population of edited cells, suitable for bulk functional assays without clonal selection bias.

HEK293T cells are a widely used derivative of the HEK293 cell line, originating from human embryonic kidney tissue. They stably express the SV40 large T antigen, which enables episomal replication of plasmids containing the SV40 origin of replication, leading to high transfectability and robust protein expression. These adherent cells are female in origin and are extensively employed in viral production, transient overexpression, and CRISPR-based genome editing studies. Their epithelial morphology and rapid growth make them an ideal platform for investigating signaling pathways and protein function.

BICC1 (BicC family RNA-binding protein 1) encodes an RNA-binding protein that post-transcriptionally regulates mRNA translation and stability. It is a critical modulator of the Wnt/??-catenin and planar cell polarity (PCP) pathways. BICC1 interacts with molecular partners including ANKS3, ANKS6, Dvl2, and Prickle1 to control the subcellular localization and translation of key Wnt components. Mechanistically, BICC1 binds to the 3?? UTRs of targets such as Cripto-1, Cyclin D1, c?Myc, and AXIN2, thereby influencing ???catenin/TCF/LEF?mediated transcription. Upstream, BICC1 is regulated by Wnt ligands (e.g., Wnt3a) and Dishevelled (Dvl). Disruption of BICC1 perturbs the balance of the Wnt signaling network, affecting processes from embryonic axis determination to kidney development.

In the HEK293T context, BICC1 knockout allows dissection of its role in a human epithelial cell line with active Wnt signaling. The loss of BICC1 may alter the expression of downstream targets like Cyclin D1 and c-Myc, impacting cell proliferation, migration, and differentiation. Because HEK293T cells are highly transfectable, this knockout model is particularly suited for rescue experiments with mutant or wild?type BICC1 constructs, luciferase reporter assays for Wnt activity, and co?transfection studies with pathway components such as Dvl2 or ???catenin. The polyclonal nature of the knockout mimics a population-level gene disruption, which can be advantageous for studying overall pathway responses without the artifacts of clonal variability.

Typical applications include investigating BICC1 function in Wnt signaling, cell migration, and colony formation, as well as small-molecule screening. Assays such as Western blotting, RT-qPCR, immunofluorescence for ??-catenin, and dual-luciferase reporters are commonly used. This model is relevant to congenital heart defects, renal cysts, and cancer. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)